Senti Biosciences Holdings Inc (SNTI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -61,438 | -52,790 | -71,058 | -58,210 | -55,319 |
| Depreciation Amortization | 3,637 | 3,838 | 5,429 | 3,920 | 3,010 |
| Accounts receivable | 210 | -712 | -929 | -131 | -395 |
| Accounts payable and accrued liabilities | 1,743 | 797 | -290 | 186 | -617 |
| Other Working Capital | 3,560 | 6,071 | 4,665 | 13,904 | 615 |
| Other Operating Activity | 8,844 | 1,399 | 9,788 | 5,435 | 18,071 |
| Operating Cash Flow | $-43,444 | $-41,397 | $-52,395 | $-34,896 | $-34,635 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 42,010 | -40,585 | N/A |
| PPE Investments | -184 | 34 | -11,933 | -41,374 | -5,543 |
| Investing Cash Flow | $-184 | $34 | $30,077 | $-81,959 | $-5,543 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 5,175 | N/A |
| Debt Repayment | N/A | N/A | -108 | N/A | N/A |
| Common Stock Issued | 11,180 | 1,806 | 887 | 1,400 | 1,500 |
| Other Financing Activity | 581 | 51,924 | 0 | 111,976 | 66,935 |
| Financing Cash Flow | $11,761 | $53,730 | $779 | $118,551 | $68,435 |
| Beginning Cash Position | 51,815 | 39,448 | 60,987 | 59,291 | 31,034 |
| End Cash Position | 19,948 | 51,815 | 39,448 | 60,987 | 59,291 |
| Net Cash Flow | $-31,867 | $12,367 | $-21,539 | $1,696 | $28,257 |
| Free Cash Flow | |||||
| Operating Cash Flow | -43,444 | -41,397 | -52,395 | -34,896 | -34,635 |
| Capital Expenditure | -196 | -26 | -12,038 | -41,374 | -5,543 |
| Free Cash Flow | -43,640 | -41,423 | -64,433 | -76,270 | -40,178 |